PINK1 Blocking Peptide
Cayman Chemical Item Number 10006284
PTEN Induced Putative Kinase 1; PARK6; BRPK
Description
Peptide sequence:
human PINK1 amino acids 484-504
·
To be used in conjunction with Cayman’s PINK1 polyclonal antibody (Catalog No. 10006283) to block protein-antibody complex formation during analysis for PINK1.
| Synonyms |
- PTEN Induced Putative Kinase 1
- PARK6
- BRPK
|
| Formulation |
200 µg of peptide in 200 µl TBS, pH 7.4, containing 0.1% BSA and 0.02% sodium azide |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
Background Reading
Unoki, M., and Nakamura, Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20 4457-4465 (2001).
Valente, E.M., Abou-Sleiman, P.M., Caputo, V., et al. Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304 1158-1160 (2004).
Mammalian Gene Collection (MGC) Program Team. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99(26) 16899-16903 (2002).
|
Pricing updated 2012-02-12.
Prices are subject to change without notice.
To ask for assistance with one of our products please contact a Technical Support Scientist.
Warning This product is not for human or veterinary use.
Downloads
Batch-specific Information
Login
to access batch-specific information
|
|
Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins.
|